KYMOS Market Share Analysis for August 2026

소분자, 생물학 제제, 핵산에 대한 생물분석 및 CMC 서비스를 제공하는 CRO입니다. GLP 및 GMP 인증을 받았으며 FDA 검사를 받았습니다.

Sports > Sports - Other

Domainkymos.com

Year Founded2001

Employees51 - 200

Annual Revenue$15M - $25M

KYMOS

KYMOS (including company regionals)

kymos.com

See more website traffic and engagement information

KYMOS Revenue up to August 2026 is 15M - 25M

revenue generated by KYMOS top domains

KYMOS top domains revenue over 3 years

Revenue for KYMOS top domains

kymos.com15M - 25M

See more with Sales Intelligence

Total visits to KYMOS's top domains

Understand KYMOS market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

kymos.com12.4K

See more with Sales Intelligence

Avg. visit duration in KYMOS's top domains

Analyze KYMOS engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

kymos.com00:03:06

See more with Sales Intelligence

Avg. pageviews on KYMOS's top domains

See how KYMOS keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

kymos.com2.53

See more with Sales Intelligence

KYMOS top competitors by domain

Top similar sites in August 2026, ranked by their affinity

coriolis-pharma.comCompany NameCoriolis PharmaEmployees51 - 200HQGermany, MontabaurAnnual revenue$15M - $25MTotal visits7.3KScience and Education > Chemistry

Top technologies used by KYMOS

These are the website technologies, by industry, used by KYMOS top domains

Widget (8)

reCAPTCHA

Advertising (4)

DoubleClick

Content Management System (4)

WordPress

Conversion & Analytics (3)

Google Analytics

More Technologies

10

See all

News & Signals from KYMOS

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsKymos Group signs new client ImmuPharma PLC.ImmuPharma selects Kymos Group as bioanalytical CRO partner for Kapiglucagon.

NewsKymos Group is developing LC-MS/MS method.In this context, Kymos has further expanded its expertise in cannabinoid bioanalysis through the development and validation of a sensitive and robust LC-MS/MS method for the simultaneous quantification of six key analytes, including CBD, THC, and their main metabolites in human plasma.

NewsKymos Group acquires Particle Analytical ApS.Kymos Group acquired Particle Analytical to strengthen its European expansion and Grifols acquired Canadian Plasma Resources to continue with its diversification strategy.